Claus Elsborg Olesen
Founder at INITIATOR PHARMA A/S
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Martin Roelsgaard Jakobsen | M | - |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 5 years |
| Ulf Simonsen | M | 61 |
University of Aarhus
| 15 years |
| Henrik Kristian Moltke | M | 66 | 8 years | |
| Gunilla Anders Ekström | M | 66 | 2 years | |
| Peter Holm | M | 50 | 8 years | |
| Annette Colin Lövgren | F | 59 | 3 years | |
| Mikael Søndergaard Thomsen | M | 56 | 8 years | |
| Gunnar Magnus Modee Persson | M | 64 | 8 years | |
| Christian Schetter | M | 60 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 5 years |
| Torgeir Vaage | M | 60 | 8 years | |
| Sten Verland | M | 67 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
| Richard Bethell | M | 61 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
| Jonathan Leslie Tobin | M | 42 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 5 years |
| Allan Wehnert | M | - | 4 years | |
| Natalie Sacks | M | 59 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 4 years |
| Regina Hodits | M | 53 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
| Morten Graugaard Døssing | M | - |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mathias Vinther | M | - |
University of Aarhus
| 8 years |
| Dan Peters | M | 63 | - | |
| Tanja Groth | M | - |
University of Aarhus
| 7 years |
| Henrik Scheel | M | - |
University of Aarhus
| 5 years |
| Johansen Jesper | M | - |
University of Aarhus
| 5 years |
| Henrik Demant | M | 52 |
University of Aarhus
| 1 years |
| Sven Vermeulen | M | - |
University of Aarhus
| - |
| Jakob Bardram | M | 56 |
University of Aarhus
| 2 years |
| Christian Sorensen | M | 44 |
University of Aarhus
| 4 years |
| Allan Larsen | M | - |
University of Aarhus
| 3 years |
| Christian Jølck | M | - |
University of Aarhus
| 2 years |
| Jacob Frandsen | M | - |
University of Aarhus
| 5 years |
| Anders Skov | M | 45 |
University of Aarhus
| 3 years |
| Dinara Kazybekovna Alimzhanova | F | 39 |
University of Aarhus
| 1 years |
| Sara Fevre Kindberg | M | - |
University of Aarhus
| 3 years |
| Fabian Söffge | M | - |
University of Aarhus
| 1 years |
| René Rømer | M | - |
University of Aarhus
| 1 years |
| Casper Lerche | M | - |
University of Aarhus
| 4 years |
| Anders Weihrauch | M | - |
University of Aarhus
| 5 years |
| Anne Gammelgaard Kaptain | F | 44 |
University of Aarhus
| 3 years |
| Jacob Jensen | M | - |
University of Aarhus
| 4 years |
| Søren Kovsted | M | - |
University of Aarhus
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 39 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Claus Elsborg Olesen
- Personal Network
